MIS Healthcare, a leading distributor in medical imaging, has successfully merged with Xiel Ltd., a specialist distributor providing nuclear medicine, radiotherapy, and diagnostic radiology solutions to the UK and Ireland. This enhances both MIS Healthcare and Xiel’s position in the rapidly growing fields of oncology and nuclear medicine and is set to drive mutual success for both companies.
Xiel works with globally leading solution providers, continually improving efficiency and quality for its customers. Xiel’s expertise lies in its deep understanding of the structure and organisation of radiotherapy, nuclear medicine, and diagnostic radiology departments, enabling them to provide tailored solutions to meet the unique needs of healthcare providers. With Xiel’s partnerships and specialised products, MIS Healthcare will strengthen its portfolio, ensuring a broader range of innovative solutions for customers across the UK and Ireland.
Jack Knight, Managing Director of Xiel, commented: “We are delighted to join forces with MIS Healthcare, an organisation that shares our commitment to delivering exceptional customer service and advancing cutting-edge technology within the healthcare sector. This merger brings an exciting opportunity to combine our extensive healthcare expertise and leverage the many synergies between our companies. Together, we will set new benchmarks in exceeding the expectations of our customers and suppliers. We look forward to this next chapter in Xiel’s journey and to achieving many future successes with MIS Healthcare.”
Mark O'Herlihy, Director of MIS Healthcare, added: “By combining MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialised expertise in nuclear medicine, radiotherapy, and diagnostic radiology, this unified platform is set to drive advancements in technology and deliver exceptional value to the healthcare community in the UK and Ireland.”
Comments